Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B244 in mild to moderate acne vulgaris
NCT02832063Phase 3Completed
- Sponsor
- AOBiome
- Start
- Aug 2016
- Primary completion
- Jul 2017
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of B244 in acne vulgaris, sponsored by AOBiome. Started Aug 2016; status: completed.
02
Drugs
B244
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02832063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02832063.